Fund Information / Factsheet • Jun 20, 2025
Fund Information / Factsheet
Open in ViewerOpens in native device viewer
Performance
Share price
Reference Index
Relative NAV
NAV



| Discrete year performance (%) |
Share price (total return) |
NAV (total return) |
|---|---|---|
| 31/3/2024 to 31/3/2025 |
13.5 | 8.7 |
| 31/3/2023 to 31/3/2024 |
9.0 | 13.5 |
| 31/3/2022 to 31/3/2023 |
-3.0 | -1.6 |
| 31/3/2021 to 31/3/2022 |
21.8 | 18.0 |
| 31/3/2020 to 31/3/2021 |
24.1 | 31.5 |
over (%) 6m 1y 3y 5y 10y
(Total return) -4.1 13.3 17.3 62.3 171.3
(Total return) -7.0 7.7 17.3 59.1 158.0
(Total return) -10.0 2.8 18.2 69.0 158.2
(Total return) 3.0 4.9 -0.9 -10.0 -0.3
All performance, cumulative growth and annual growth data is sourced from Morningstar.
Source: at 31/05/25. © 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not predict future returns.
The Investment management and administration transferred to Janus Henderson Investors on 1 August 2024.
In the month under review the Company's NAV total return was 4.0% and the Russell 1000® Value Index total return was 2.5%.
The overweight position and stock selection in the technology sector contributed positively, while the healthcare holdings detracted from performance.
We believe companies held in the portfolio are well positioned for a period of volatility. Their high-quality nature should help insulate them against some of the macroeconomic forces at play.
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
The Company aims to provide investors with above average dividend income and long-term capital growth through active management of a portfolio consisting predominantly of S&P 500 US equities.
Seeks to provide income with the potential for growth, offering UK investors diversification through exposure to the US.
| NAV (cum income) | 348.1p |
|---|---|
| NAV (ex income) | 344.0p |
| Share price | 318.0p |
| Discount(-)/premium(+) | -8.6% |
| Yield | 3.8% |
| Net gearing | 6% |
| Net cash | - |
| Total assets Net assets |
£456m £422m |
| Market capitalisation | £386m |
| Total voting rights | 121,309,836 |
| Total number of holdings | 53 |
| Ongoing charges (year end 31 Jan 2025) |
0.77% |
| Reference Index | Russell 1000® Value Index |
Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used.
Please note that the total voting rights in the Company do not include shares held in Treasury.
The Company has no benchmark, but the most relevant reference index for the Company is the Russell 1000 Value Index (in sterling terms) and most of the holdings in the portfolio are likely to be drawn from its constituents.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
Go to www.janushenderson.com/howtoinvest
Factsheet - at 31 May 2025 Marketing Communication
| Top 10 holdings | (%) |
|---|---|
| Philip Morris International | 4.5 |
| Chevron | 4.1 |
| Lamar Advertising | 3.2 |
| CVS Health | 3.2 |
| Morgan Stanley | 3.2 |
| Gaming and Leisure Properties | 3.1 |
| Enbridge | 3.1 |
| Xcel Energy | 2.9 |
| PNC Financial Services Group | 2.9 |
| CMS Energy | 2.6 |
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.



The above sector breakdown may not add up to 100% due to rounding.

All performance, cumulative growth and annual growth data is sourced from Morningstar. Share price total return is calculated using mid-market share price with dividends reinvested.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
Regional focus North America Fund manager appointment Jeremiah Buckley 2024

Fran Radano, CFA Portfolio Manager

Customer services 0800 832 832
How to invest
Go to www.janushenderson.com/howtoinvest

US equities strengthened in May as cooling US/China trade tensions increased hopes that the US could avoid a recession. Robust jobs growth also cheered investors, although weaker corporate results caused some jitters. The market's reaction to the US trade court's ruling against the government was relatively muted, given the likelihood that President Trump could resort to other measures to implement tariff increases.
Some solid corporate results boosted the information technology (IT) sector. Meanwhile, the healthcare sector fared worst, as more defensive sectors fell out of favour as risk sentiment improved.
Consumer prices rose by a weaker-than-anticipated 2.3% in April, which marked a more than four-year low and was down from March's 2.4% increase. Despite the more muted inflation figures, the US Federal Reserve (Fed) remains in a holding pattern on interest rates, given the inflationary risks of the pending tariffs. The contraction in first-quarter GDP growth was revised to an annualised 0.2% from a previous estimate of 0.3%.
The overweight position and stock selection in the technology sector were both positive for performance over the month. In terms of individual holdings, semiconductor manufacturer Broadcom was a key
positive contributor as the company reported secondquarter earnings that were ahead of expectations. Both Dell Technologies and Microsoft also contributed positively as sentiment around IT in general improved. The holding in Morgan Stanley was another positive contributor.
Conversely, healthcare was one of the sectors to underperform over the month. Dr Vinay Prasad, a pharmaceutical industry critic, was appointed to a key role in the US Food and Drug Administration (FDA) and there was robust discussion around pharmacy benefit managers (PBMs) which are a critical component of the businesses of United Healthcare and CVS Health. Therefore, both holdings underperformed and detracted from performance.
During the extreme volatility earlier in the year, we had trimmed some of the more defensive holdings and added both secular growth-style stocks and some cyclical stocks (those more dependent on a positive overall economy to do well) that had seen their share prices fall more than we believed was warranted. This process continued in May. So, we bought Danaher, a life sciences and diagnostic services company, as we believed we were purchasing a high-quality company at a very fair price. We sold out of Oracle Technology, as we believed the risk-reward was more balanced and we had more preferred holdings that addressed similar end markets. We also sold out of energy company Phillips 66 and used the activist involvement to consolidate our energy holdings into what we saw as higher-quality holdings.
We continue to see good fundamentals in our holdings. However, given the backdrop, most management teams of the companies we hold have introduced conservative guidance (forecasts) for 2025. Given the elevated volatility in the market, we were able to add to many positions in what we see as high-quality companies that we believe embedded a worse-case scenario (which we did not believe would occur).
Dividend growth remains strong and, perhaps more importantly, predictable. We expect this trend to continue throughout the year. We are currently expecting mid- to high-single digit dividend growth based on our current holdings and what the team has modelled.
As the new administration attempts to more aggressively recalibrate global trade rules and regulations, there have been signs of a slowdown in economic activity. This pause in corporate activity may mute economic growth (and thus company earnings) in the near term. As a result, we expect to see continued volatility as trade negotiations begin in earnest. Conversely, we think the benefits of deregulation should improve the operating environment for companies across multiple sectors, including financials and energy.
The consumer backdrop remains positive due to a strong labour market. However, both the reduction in corporate

activity, and a volatile stock market impacting the net worth of consumers, have the potential to reduce spending, despite strong equity market performance in recent years and higher interest earnings on cash - both of which have supported the consumer. Debt service below long-term norms does provide a reduction in risk, especially when compared to prior periods of consumer weakness.
In addition, labour productivity trends remain positive, supporting wage growth and corporate profitability. AI integration across sectors is enhancing efficiency and reducing costs, and we have recently seen practical examples in the healthcare, e-commerce, finance and energy sectors. While AI adoption is still early, its potential for significant impact on productivity and revenue growth seems clear.
We continue to be excited about the innovation and productivity gains that large US companies continue to drive through capital and research and development (R&D) spending. The investments required to stay relevant and prosper in the new digital economy are significant and hence favour the largest companies that lead their industries. Having large amounts of data that can inform strategy and execution has become critical. We have populated the portfolio with companies that have the scale to make these investments, which we believe should drive growth in earnings and dividends for years to come.
manage through a period of volatility. We also feel comfortable with the current valuations of these companies, which in aggregate were trading at a discount to market multiples (at the time of writing). We feel the high-quality nature of these holdings should help insulate them against some of the macroeconomic forces at play. From a revenue perspective, we think the historically predictable cash generation and robust balance sheets should lead to continued dividend growth prospects for 2025. We continue to seek resilient companies, where macroeconomic tailwinds are not needed for growth and that have the cash and ability to invest in themselves for the future.
We believe the companies we hold are well positioned to

The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Share price multiplied by the number of shares in issue, excluding treasury shares, at month end. Shares typically priced mid-market at month-end closing.
The total value of a Company's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit: https://www.janushenderson.com/en-gb/investor/glossary/ Factsheet - at 31 May 2025 Marketing Communication

Source for fund ratings/awards Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Company specific risks
Janus Henderson Fund Managers UK Limited was appointed as the AIFM of the North American Income Trust with effect from 1 August 2024. Prior to that date, the North American Income Trust's AIFM was abrdn Fund Managers Limited and all information contained in this document should be considered accordingly.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority), Tabula Investment Management Limited (reg. no. 11286661 at 10 Norwich Street, London, United Kingdom, EC4A 1BD and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 78, Avenue de la Liberté, L-1930 Luxembourg, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
Janus Henderson is a trademark of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.